Source:http://linkedlifedata.com/resource/pubmed/id/14597470
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2003-11-4
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants,
http://linkedlifedata.com/resource/pubmed/chemical/Factor VII,
http://linkedlifedata.com/resource/pubmed/chemical/Factor VIIa,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/recombinant FVIIa
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1539-3704
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
4
|
pubmed:volume |
139
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
791
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading | |
pubmed:year |
2003
|
pubmed:articleTitle |
Laboratory monitoring of high-dose factor VIIa therapy.
|
pubmed:publicationType |
Letter,
Comment
|